Client
Year
Type
2022
Novo Nordisk
App and HCP portal
Digital design, App screen
Data visualisation detail
Leveraging expectations.
Driving engagement.
From early 2021, a series of Interviews were conducted to HCPs and patients across the APAC region. The questions were directed to detect pain points from stakeholders who were diagnosed with Obesity and health care professionals who were treating the disease. The information that we received were in the form of user stories, this allowed us to understand pains along the user journey.
My role at this stage was to synthesise the data into key insights to help accommodate user needs across the APAC region whilst answer commercial needs. The underlying factor was to generate habits within the user to drive activity whilst nurturing the patients to make progression but what would it take to build that engagement?
In order to do so, we needed to create a clear narrative to help the team understand how our product fits plays an integral part of the lives our users. To make sure we did that we ran a series of workshops with the team and the clients to help create an array of behavioural archetypes, empathy maps and service blueprints.
WE FOUND OUT
80% of patients are dropping out of treatment after 3 months
Understanding our users fast and interate.
Based on UX principles we were were able to generate clear hypothesis based on several assumptions and then analysing the prioritised insights were able to formulate 'How might We?' questions.
We ran a workshop with the clients to present pain points that crossed over from market to market which we felt that should be prioritised. We also presented commercial success goals that should be prioritised. These were presented in handmade sketches.
Hand made sketches
Formulating user flows and wireframes
Before starting the project starting a series of tests were conducted on HCPs in Iran, Joran, Saudi Arabia and UAE. It was noticed that people diagnosed with obesity are generally not achieving their treatment goals with up to 80% dropping out of treatment after three months.
This is a complex problem that stems from both the patient’s lack of guidance and the clinician’s lack of resources. Patients miss personalised adjustment plans, continual motivation, and a place to track and record sustainable habits while clinicians lack the resources demanded of them when treating and managing people with obesity.
Wireframe designs were conducted to represent a low fidelity of the user flows. This helped us save time to help make sure that crucial step were taken into consideration before spending time on higher fidelity designs.
Wireframe, digital design
Imagery, Illustration
Digital design, app blueprint
Information flows
The invention of MotivO was primarily because Novo Nordisk released their new drug to treat Obesity. Creating information architecture helped the process by easily indicating how users can switch from Saxenda to Wegovy.
New treatment plan screens
Motivo 1.0
The MotivO 1.0 had an unpersonalised look and feel. It was obvious to me that the grey background and the dark blue felt quite masculine. The visualisation of the interface looked very clinical. The clinical look can reduce the personalised connection with the app, which ultimately can reduce engagement with the app which could affect the users adherence to taking their daily medicine.
We wanted to add warm appealing colours to the design to interject a friendly tone of voice and a environment that was welcoming, trustworthy and motivating.
Old version and new UI
Conceptual mood board
UI element
The home page was crafted to help generate motivation, manage their treatment and have a personalised overview of their progression
List of the 9 features
Buddy
Insights
Diary
Journey
Data capture
Progress
Treatment
Personalised reminder and feedback
Home page and treatment agnostics
Home page
Insights page
Illustration themes
Imagery
